Randomized Trial Comparing 5-Year Follow-Up of First-Line Infliximab to Conventional Therapy in Pediatric Crohn’s Disease
Vuijk, S. A., Jongsma, M. M. E., Cozijnsen, M. A., van Pieterson, M.,
de Meij, T. G. J., Groeneweg, M., Wolters, V. M.,
van Wering, H., Hojsak, I., Kolho, K.-L.,
Hummel, T., Stapelbroek, J., van der Feen, C.,
van Rheenen, P. F.,
van Wijk, M. P., Teklenburg-Roord, S., Pruijsen-Nienhuis, J. M., Rizopoulos, D., Escher, J. C. &
Samsom, J. N. & 1 others,
de Ridder, L.,
2026, (E-pub ahead of print)
In: Clinical Gastroenterology and Hepatology.Research output: Contribution to Journal › Article › Academic › peer-review